Phillip Frost, M.D. (Chairman)
Dr. Phillip Frost is the Chairman of the Board of PROLOR Biotech. He currently serves as CEO and Chairman of Opko Health, Inc. (OPK-NYSE AMEX).
Dr. Frost is the Chairman of the Board of Teva Pharmaceuticals (TEVA-NASDAQ). In January 2006 Teva acquired IVAX Corporation. Dr. Frost had served as chairman of the Board of directors and CEO of IVAX Corporation since 1987.
Dr. Frost was named chairman of the Board of Ladenburg Thalmann & Co., Inc., (LTS-AMEX), an American Stock Exchange-listed investment banking and securities brokerage firm, in July 2006 and has been a director of Ladenburg Thalmann since March 2005.
He serves on the Board of Regents of the Smithsonian Institution, a member of the Board of Trustees of the University of Miami, a Trustee of each of the Scripps Research Institutes, the Miami Jewish Home for the Aged, and the Mount Sinai Medical Center, and is Vice Chairman of the Board of Governors of the American Stock Exchange.
Dr. Frost received a B.A. in French literature from the University of Pennsylvania in 1957 and an M.D. from the Albert Einstein College of Medicine in 1961.